vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and Hillenbrand, Inc. (HI). Click either name above to swap in a different company.
Hillenbrand, Inc. is the larger business by last-quarter revenue ($550.2M vs $359.9M, roughly 1.5× AdvanSix Inc.). Hillenbrand, Inc. runs the higher net margin — -0.4% vs -0.8%, a 0.4% gap on every dollar of revenue. On growth, AdvanSix Inc. posted the faster year-over-year revenue change (9.4% vs -22.2%). AdvanSix Inc. produced more free cash flow last quarter ($36.1M vs $-31.6M). Over the past eight quarters, AdvanSix Inc.'s revenue compounded faster (3.4% CAGR vs -16.3%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
Hillenbrand, Inc. is a global diversified industrial firm that designs, manufactures, and distributes specialized processing equipment and durable industrial solutions. It serves food & beverage, agriculture, manufacturing, waste management sectors, with operations across North America, Europe, and APAC.
ASIX vs HI — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $359.9M | $550.2M |
| Net Profit | $-2.8M | $-2.2M |
| Gross Margin | 7.6% | 33.4% |
| Operating Margin | -0.7% | -2.2% |
| Net Margin | -0.8% | -0.4% |
| Revenue YoY | 9.4% | -22.2% |
| Net Profit YoY | -892.9% | -134.4% |
| EPS (diluted) | $-0.11 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $359.9M | $550.2M | ||
| Q3 25 | $374.5M | $652.1M | ||
| Q2 25 | $410.0M | $598.9M | ||
| Q1 25 | $377.8M | $715.9M | ||
| Q4 24 | $329.1M | $706.9M | ||
| Q3 24 | $398.2M | $837.6M | ||
| Q2 24 | $453.5M | $786.6M | ||
| Q1 24 | $336.8M | $785.3M |
| Q4 25 | $-2.8M | $-2.2M | ||
| Q3 25 | $-2.6M | $75.7M | ||
| Q2 25 | $31.4M | $1.9M | ||
| Q1 25 | $23.3M | $-40.9M | ||
| Q4 24 | $352.0K | $6.4M | ||
| Q3 24 | $22.3M | $14.6M | ||
| Q2 24 | $38.9M | $-248.9M | ||
| Q1 24 | $-17.4M | $6.1M |
| Q4 25 | 7.6% | 33.4% | ||
| Q3 25 | 6.8% | 34.8% | ||
| Q2 25 | 14.3% | 33.8% | ||
| Q1 25 | 14.2% | 33.0% | ||
| Q4 24 | 3.4% | 33.2% | ||
| Q3 24 | 14.4% | 34.4% | ||
| Q2 24 | 17.9% | 33.9% | ||
| Q1 24 | 0.9% | 31.9% |
| Q4 25 | -0.7% | -2.2% | ||
| Q3 25 | -0.9% | — | ||
| Q2 25 | 7.7% | 1.8% | ||
| Q1 25 | 7.7% | -6.2% | ||
| Q4 24 | -3.9% | 2.2% | ||
| Q3 24 | 7.5% | — | ||
| Q2 24 | 11.5% | -32.7% | ||
| Q1 24 | -7.0% | 1.6% |
| Q4 25 | -0.8% | -0.4% | ||
| Q3 25 | -0.7% | 11.6% | ||
| Q2 25 | 7.7% | 0.3% | ||
| Q1 25 | 6.2% | -5.7% | ||
| Q4 24 | 0.1% | 0.9% | ||
| Q3 24 | 5.6% | 1.7% | ||
| Q2 24 | 8.6% | -31.6% | ||
| Q1 24 | -5.2% | 0.8% |
| Q4 25 | $-0.11 | — | ||
| Q3 25 | $-0.10 | $1.07 | ||
| Q2 25 | $1.15 | $0.03 | ||
| Q1 25 | $0.86 | $-0.58 | ||
| Q4 24 | $0.02 | $0.09 | ||
| Q3 24 | $0.82 | $0.20 | ||
| Q2 24 | $1.43 | $-3.53 | ||
| Q1 24 | $-0.65 | $0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | $173.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $815.2M | $1.4B |
| Total Assets | $1.7B | $4.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.8M | $173.1M | ||
| Q3 25 | $23.7M | $164.8M | ||
| Q2 25 | $18.4M | $162.8M | ||
| Q1 25 | $8.3M | $458.4M | ||
| Q4 24 | $19.6M | $208.0M | ||
| Q3 24 | $17.3M | $199.3M | ||
| Q2 24 | $12.1M | $223.8M | ||
| Q1 24 | $20.6M | $224.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | $1.5B | ||
| Q2 25 | — | $1.7B | ||
| Q1 25 | — | $1.9B | ||
| Q4 24 | — | $1.9B | ||
| Q3 24 | — | $1.9B | ||
| Q2 24 | — | $2.1B | ||
| Q1 24 | — | $2.1B |
| Q4 25 | $815.2M | $1.4B | ||
| Q3 25 | $818.2M | $1.4B | ||
| Q2 25 | $823.7M | $1.3B | ||
| Q1 25 | $794.4M | $1.3B | ||
| Q4 24 | $774.6M | $1.4B | ||
| Q3 24 | $766.4M | $1.4B | ||
| Q2 24 | $746.6M | $1.4B | ||
| Q1 24 | $713.2M | $1.7B |
| Q4 25 | $1.7B | $4.5B | ||
| Q3 25 | $1.7B | $4.5B | ||
| Q2 25 | $1.6B | $4.7B | ||
| Q1 25 | $1.6B | $4.8B | ||
| Q4 24 | $1.6B | $5.1B | ||
| Q3 24 | $1.5B | $5.2B | ||
| Q2 24 | $1.5B | $5.3B | ||
| Q1 24 | $1.5B | $5.6B |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 1.27× | ||
| Q1 25 | — | 1.44× | ||
| Q4 24 | — | 1.38× | ||
| Q3 24 | — | 1.33× | ||
| Q2 24 | — | 1.48× | ||
| Q1 24 | — | 1.28× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | $-27.4M |
| Free Cash FlowOCF − Capex | $36.1M | $-31.6M |
| FCF MarginFCF / Revenue | 10.0% | -5.7% |
| Capex IntensityCapex / Revenue | 7.7% | 0.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | $7.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.7M | $-27.4M | ||
| Q3 25 | $26.6M | $67.7M | ||
| Q2 25 | $21.1M | $-1.5M | ||
| Q1 25 | $11.4M | $1.3M | ||
| Q4 24 | $64.2M | $-11.3M | ||
| Q3 24 | $57.3M | $166.5M | ||
| Q2 24 | $50.2M | $45.6M | ||
| Q1 24 | $-36.2M | $3.2M |
| Q4 25 | $36.1M | $-31.6M | ||
| Q3 25 | $66.0K | $58.6M | ||
| Q2 25 | $-7.2M | $-11.2M | ||
| Q1 25 | $-22.6M | $-8.0M | ||
| Q4 24 | $29.8M | $-21.5M | ||
| Q3 24 | $26.8M | $153.4M | ||
| Q2 24 | $16.7M | $29.7M | ||
| Q1 24 | $-71.6M | $-9.6M |
| Q4 25 | 10.0% | -5.7% | ||
| Q3 25 | 0.0% | 9.0% | ||
| Q2 25 | -1.7% | -1.9% | ||
| Q1 25 | -6.0% | -1.1% | ||
| Q4 24 | 9.1% | -3.0% | ||
| Q3 24 | 6.7% | 18.3% | ||
| Q2 24 | 3.7% | 3.8% | ||
| Q1 24 | -21.3% | -1.2% |
| Q4 25 | 7.7% | 0.8% | ||
| Q3 25 | 7.1% | 1.4% | ||
| Q2 25 | 6.9% | 1.6% | ||
| Q1 25 | 9.0% | 1.3% | ||
| Q4 24 | 10.4% | 1.4% | ||
| Q3 24 | 7.7% | 1.6% | ||
| Q2 24 | 7.4% | 2.0% | ||
| Q1 24 | 10.5% | 1.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.89× | ||
| Q2 25 | 0.67× | -0.79× | ||
| Q1 25 | 0.49× | — | ||
| Q4 24 | 182.29× | -1.77× | ||
| Q3 24 | 2.57× | 11.40× | ||
| Q2 24 | 1.29× | — | ||
| Q1 24 | — | 0.52× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
HI
| Transferred At Point In Time | $256.5M | 47% |
| Transferred Over Time | $207.1M | 38% |
| Molding Technology Solutions | $86.6M | 16% |
